Outcomes of Rivaroxaban and Aspirin in PAD After Endovascular Revascularization

NCT05308030 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Arterial Disease

Interventions

DRUG: Rivaroxaban and Aspirin

Sponsor

Assiut University